Mechanisms of somatic mtDNA mutation detection and elimination
体细胞线粒体DNA突变检测和消除机制
基本信息
- 批准号:8914069
- 负责人:
- 金额:$ 23.18万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-09-01 至 2017-08-31
- 项目状态:已结题
- 来源:
- 关键词:AgingAnimal ModelAutophagocytosisBiological AssayBiological ModelsBiological ProcessCollaborationsDNADNA-Directed DNA PolymeraseDiabetes MellitusDiseaseDoseDrosophila genusDrosophila melanogasterElderlyExcisionFrequenciesGeneticGenetic ModelsHealthKnowledgeLeadLocomotionLongevityLysosomesMalignant NeoplasmsMediatingMethodsMitochondriaMitochondrial DNAMolecularMorphogenesisMutateMutationMutation DetectionPINK1 geneParkinson DiseasePathogenesisPathologyPhenotypePhysiologicalPlayProcessProtein-Serine-Threonine KinasesProteomicsQuality ControlRoleSeverity of illnessSurfaceSystemTestingTissuesToxic effectTransgenesTransgenic OrganismsUbiquitin-Protein Ligase ComplexesUbiquitinationUrsidae FamilyWorkflygenetic manipulationhuman diseasein vivoinsightlocomotor deficitmitochondrial DNA mutationmutantnext generation sequencingnoveloverexpressionparkin gene/proteinresearch studytherapy developmenttraffickingubiquitin-protein ligase
项目摘要
DESCRIPTION (provided by applicant): Mitochondrial DNA (mtDNA) mutations cause a number of severe maternally transmitted diseases, and the accumulation of somatic mtDNA mutations is implicated in aging and common diseases of the elderly. These mtDNA mutations often coexist with normal mtDNA, a condition known as heteroplasmy. The ratio of mutated to wild-type mtDNA plays a crucial role in the pathogenesis of heteroplasmic disorders, but the mechanisms that influence this ratio are largely unknown. The long-term objective of our work is to define the cellular mechanisms that govern the frequency of deleterious mtDNA mutations in heteroplasmic somatic tissues. Recent work on the Parkinson's disease-related factors PINK1 and Parkin has revealed that these factors are components of a mitochondrial quality control system (MQCS) that can detect dysfunctional mitochondria, and, in collaboration with other cellular factors, promote their autophagic degradation. We hypothesize that the MQCS acts to reduce the frequency of deleterious heteroplasmic mtDNA mutations by detecting dysfunctional mitochondria that bear mutant DNA and targeting them for degradation. To test this hypothesis, we propose to use the model organism Drosophila melanogaster to pursue three aims. The first aim will examine the influence of genetic alterations of the MQCS on the phenotypes of a Drosophila strain with an increased mtDNA mutation frequency. The second aim will examine the influence of genetic perturbations of the MQCS on the mtDNA mutation frequency using a novel next-generation sequencing method. Finally, the third aim will use a recently developed in vivo assay of mitochondrial turnover to test whether mtDNA mutations promote mitochondrial turnover, and whether genetic perturbations of the MQCS influence the effects of mtDNA mutations on turnover. Our studies will contribute to an understanding of the molecular mechanisms that influence heteroplasmy, and this knowledge could ultimately lead to the development of treatments for diseases caused by mtDNA mutations.
描述(申请人提供):线粒体DNA(MtDNA)突变导致许多严重的母系传播疾病,体细胞mtDNA突变的积累与老年人的衰老和常见病有关。这些线粒体DNA突变通常与正常的线粒体DNA共存,这种情况被称为异质性。突变mtDNA与野生型mtDNA的比例在异质性疾病的发病机制中起着至关重要的作用,但影响这一比例的机制在很大程度上尚不清楚。我们工作的长期目标是确定控制异质体细胞组织中有害mtDNA突变频率的细胞机制。最近对帕金森病相关因子PINK1和Parkin的研究表明,这些因子是线粒体质量控制系统(MQCS)的组成部分,可以检测功能障碍的线粒体,并与其他细胞因子合作,促进其自噬降解。我们假设MQCS通过检测携带突变DNA的功能失调的线粒体并针对它们进行降解来减少有害的异质性mtDNA突变的频率。为了验证这一假设,我们建议使用模式生物黑腹果蝇来追求三个目标。第一个目的是研究MQCS的遗传变化对线粒体DNA突变频率增加的果蝇品系表型的影响。第二个目标将使用新的下一代测序方法来检查MQCS的遗传扰动对mtDNA突变频率的影响。最后,第三个目标将使用最近开发的体内线粒体周转试验来测试mtDNA突变是否促进线粒体周转,以及MQCS的遗传扰动是否影响mtDNA突变对周转的影响。我们的研究将有助于理解影响异质性的分子机制,这一知识最终可能导致mtDNA突变引起的疾病治疗的发展。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Leo J Pallanck其他文献
Leo J Pallanck的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Leo J Pallanck', 18)}}的其他基金
Mechanism of innate immune activation in a Drosophila model of Alzheimer's disease related dementia
阿尔茨海默病相关痴呆果蝇模型中先天免疫激活机制
- 批准号:
10339866 - 财政年份:2022
- 资助金额:
$ 23.18万 - 项目类别:
Mechanism of innate immune activation in a Drosophila model of Alzheimer's disease related dementia
阿尔茨海默病相关痴呆果蝇模型中先天免疫激活机制
- 批准号:
10554427 - 财政年份:2022
- 资助金额:
$ 23.18万 - 项目类别:
Mechanism and importance of innate immune activation in a Drosophila GBA mutant model of Parkinson's disease
帕金森病果蝇 GBA 突变模型中先天免疫激活的机制和重要性
- 批准号:
10259742 - 财政年份:2020
- 资助金额:
$ 23.18万 - 项目类别:
Mechanism and importance of innate immune activation in a Drosophila GBA mutant model of Parkinson's disease
帕金森病果蝇 GBA 突变模型中先天免疫激活的机制和重要性
- 批准号:
10039929 - 财政年份:2020
- 资助金额:
$ 23.18万 - 项目类别:
Mechanisms of non-cell-autonomous regulation of brain protein aggregation in Drosophila
果蝇脑蛋白聚集的非细胞自主调节机制
- 批准号:
9791153 - 财政年份:2018
- 资助金额:
$ 23.18万 - 项目类别:
Therapeutic Potential of Small Molecule Activators of the PINK1-Parkin Pathway
PINK1-Parkin 通路小分子激活剂的治疗潜力
- 批准号:
8806805 - 财政年份:2015
- 资助金额:
$ 23.18万 - 项目类别:
A Drosophila model for studying mechanisms of Gaucher's disease and synucleinopathies
用于研究戈谢病和突触核蛋白病机制的果蝇模型
- 批准号:
9351579 - 财政年份:2015
- 资助金额:
$ 23.18万 - 项目类别:
A proteomic approach to identify substrates of the AAA+ mitochondrial proteases
鉴定 AAA 线粒体蛋白酶底物的蛋白质组学方法
- 批准号:
9128054 - 财政年份:2015
- 资助金额:
$ 23.18万 - 项目类别:
Therapeutic Potential of Small Molecule Activators of the PINK1-Parkin Pathway
PINK1-Parkin 通路小分子激活剂的治疗潜力
- 批准号:
8996662 - 财政年份:2015
- 资助金额:
$ 23.18万 - 项目类别:
A proteomic approach to identify substrates of the AAA+ mitochondrial proteases
鉴定 AAA 线粒体蛋白酶底物的蛋白质组学方法
- 批准号:
9015991 - 财政年份:2015
- 资助金额:
$ 23.18万 - 项目类别:
相似海外基金
Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
- 批准号:
495434 - 财政年份:2023
- 资助金额:
$ 23.18万 - 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
- 批准号:
10586596 - 财政年份:2023
- 资助金额:
$ 23.18万 - 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
- 批准号:
10590479 - 财政年份:2023
- 资助金额:
$ 23.18万 - 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
- 批准号:
10642519 - 财政年份:2023
- 资助金额:
$ 23.18万 - 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
- 批准号:
23K06011 - 财政年份:2023
- 资助金额:
$ 23.18万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
- 批准号:
10682117 - 财政年份:2023
- 资助金额:
$ 23.18万 - 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
- 批准号:
10708517 - 财政年份:2023
- 资助金额:
$ 23.18万 - 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
- 批准号:
10575566 - 财政年份:2023
- 资助金额:
$ 23.18万 - 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
- 批准号:
23K15696 - 财政年份:2023
- 资助金额:
$ 23.18万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
- 批准号:
23K15867 - 财政年份:2023
- 资助金额:
$ 23.18万 - 项目类别:
Grant-in-Aid for Early-Career Scientists